Filing Details
- Accession Number:
- 0001209191-24-003922
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-23 20:02:29
- Reporting Period:
- 2024-02-21
- Accepted Time:
- 2024-02-23 20:02:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1124140 | Exact Sciences Corp | EXAS | Services-Medical Laboratories (8071) | 204782291 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1957680 | James Herriott | C/O Exact Sciences Corp. 5505 Endeavor Lane Madison WI 53719 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-02-21 | 581 | $0.00 | 7,524 | No | 4 | A | Direct | |
Common Stock | Disposition | 2024-02-22 | 291 | $59.78 | 7,233 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,183 | Indirect | Held in 401(k) Plan |
Footnotes
- Represents shares of common stock received upon settlement of a performance share unit award on February 21, 2024.
- Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units.
- In addition to the shares of Common Stock reported on this Form 4, which total 8,416 shares, Mr. Herriott also holds, in the aggregate, an additional 17,019 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.